WallStEquities.com is offering reports on LIVN, MASI, MDT, and MDXG.
NEW YORK, April 27, 2018 /PRNewswire/ -- WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on LIVN, MASI, MDT, and MDXG which can be accessed for free by signing up to www.wallstequities.com/registration. Research reports have been issued by WallStEquities.com on LivaNova PLC (NASDAQ: LIVN), Masimo Corp. (NASDAQ: MASI), Medtronic PLC (NYSE: MDT), and MiMedx Group Inc. (NASDAQ: MDXG). Medical Appliances and Equipment companies engage in the manufacture of medical instruments such as dental and surgical appliances. They tend to offer below-average dividend yields when compared to the wider market. All you have to do is sign up today for this free limited time offer by clicking the link below.
www.wallstequities.com/registration
LivaNova
On Thursday, shares in London, the UK headquartered LivaNova PLC recorded a trading volume of 235,958 shares. The stock ended the session 1.10% higher at $88.35. The Company’s shares have gained 68.32% in the past twelve months. The stock is trading above its 50-day and 200-day moving averages by 1.65% and 14.39%, respectively. Moreover, shares of LivaNova, which designs, develops, manufactures, and sells therapeutic solutions worldwide, have a Relative Strength Index (RSI) of 55.41. Get the full research report on LIVN for free by clicking below at:
www.wallstequities.com/registration/?symbol=LIVN
Masimo
Irvine, California headquartered Masimo Corp.'s stock closed the day 2.01% higher at $90.63 with a total trading volume of 385,392 shares. The Company’s shares have advanced 5.85% in the past month. The stock is trading above its 50-day and 200-day moving averages by 4.89% and 3.79%, respectively. Additionally, shares of Masimo, which develops, manufactures, and markets noninvasive monitoring technologies worldwide, have an RSI of 62.87. Access the free research report on MASI now by signing up at:
www.wallstequities.com/registration/?symbol=MASI
Medtronic
Shares in Dublin, Ireland headquartered Medtronic PLC recorded a trading volume of 5.12 million shares. The stock ended yesterday’s trading session 1.42% higher at $80.59. The Company’s shares have advanced 3.11% in the past month. The stock is trading above its 50-day moving average by 0.52%. Furthermore, shares of Medtronic, which manufactures and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide, have an RSI of 54.63. Are you already registered with Wall St. Equities? Do so now for free, and get the report on MDT at:
www.wallstequities.com/registration/?symbol=MDT
MiMedx Group
Marietta, Georgia headquartered MiMedx Group Inc.'s stock finished Thursday’s session 3.88% lower at $7.92 with a total trading volume of 3.38 million shares. The Company’s shares have advanced 17.68% in the last month. The stock is trading below its 50-day moving average by 0.81%. Additionally, shares of MiMedx, which develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare, have an RSI of 61.52. Aspiring Member, please take a moment to register below for your free research report on MDXG at:
www.wallstequities.com/registration/?symbol=MDXG
--
Wall St. Equities:
Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
WSE has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
NO WARRANTY
WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
